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General Introduction
The estrogen receptor is a protein responsible for the binding of the female sex hormone 
estradiol in a variety of physiological systems.1 One system in which its presence is particularly 
interesting from a clinical point of view is breast tumors. Upon inception of a malignancy, the 
cells contained therein may retain either all or very few of their original nuclear estrogen receptor 
sites. The presence or absence of these sites provides a criterion by which the tumors can be 
divided into two classes: hormone dependent and hormone independent. Hormone dependent 
cells do contain a significant number of estrogen receptors, which makes their growth succeptible 
to external hormonal manipulation.2 Hormone independent tumors however, are impervious to 
such influences, having somehow lost the bulk of their estrogen receptors during malignant 
progression.
ER levels are typically determined by the DCC (dextran-coated charcoal) method, which 
uses a cell homogenate from biopsied tissue, incubated with radiolabelled hormone,3 to arrive at 
what cculd be called a "cell-averaged" receptor count. Unfortunately, this method has an 
unacceptable track record with respect to predicting the success of endocrine therapy (involving 
either surgical removal of endocrine tissues or administration of anti-estrogens). ER- cells (those 
displaying absence of estrogen receptor by the DCC method) do correlate well for hormone 
unresponsiveness to endocrine therapy (less than 10% do respond). The problem lies with ER+ 
cells (those determined to contain sufficient levels of estrogen receptor to be treatable by endocrine 
therapy). In this case, there is only 50-70% correlation.4
The commonly recognized cause for unresponsiveness in ER+ tumor cells is heterogeneity 
of the receptor distribution throughout the cells.5 This situation would certainly render 
meaningless the "cell-averaged" receptor-level values found in DCC assays. While most cells in a 
given tumor may contain significant numbers of estrogen receptor sites, there may be some cells in 
the same tumor with too few receptor sites to be influenced by endocrine therapy.6 A tumor of this 
composition would appear ER+, but a portion of it would continue to grow in the presence of anti­
estrogens. This suggests the need for a method that would address the issue of cell-by-cell 
quantitation of estrogen receptor, thus circumventing the problems inherent in the DCC assay.
A promising alternative to the DCC assay is the development of receptor-targeted 
fluorescent ligands. Ligands of this type could allow detection of ER+ tumor cells by either 
fluorescence microscopy or flow cytometry.7 Criteria for an effective fluorescent estrogen arc 
spectroscopic as well as biological. Biologically, the ligand must exhibit high (and highly specific) 
binding affinity for the estrogen receptor. Since on average there are between 10,000 and 20,000 
ER/cell,8 high fluorescent quantum yield is a major spectroscopic requirement. Also, the emission 
wavelength of the fluorophore should be distinct from the range of cellular autofluorescence (>500 
nm).9 To these ends, and mindful of the above criteria, we have focused our attentions on the 
elaboration of the 2,3 diarylindene skeleton to create novel and potentially effective integrated 
fluorescent estrogens.
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The 2,3-diary Undone (1) has been found to be an inherently fluorescent ER ligand.1 
Unfortunately, it is a poor one, having an RBA (relative binding affinity; numerical scale based on 
estradiol ~ 1(X)) of only 9 and a maximum emission wavelength of only 420 nm, well within the 
range of cellular autofluorescence.2
The 2,3-diphenylindenone (2) showed a higher RBA (59), but decreased fluorescence due 
to intersystem crossing induced by the carbonyl at C -l.1 Upon examination of crystallographic 
results obtained for (1) and (2), it was determined that the increase in RBA was due to increased 
torsional angles of the two pendant aryl rings.1 This observation led to attempts to increase the 
torsional angles without interfering with the fluorescence properties conferred upon this system by 
its trans-stilbene chromophore.3 It was also determined1 that the desired wavelength of emission 
could be obtained through the incorporation of a donor/acccptor system.4 Therefore, modifications 
were made by placing substituents in the ^-positions of the 2- and 3- rings to increase the torsional 
angles, along with the incorporation of a second donor in the p-position of the 3-ring, resulting in 
the synthesis of compounds (3a-c).
RESULTS AND .DISCUSSION
$. The 2,3-diarylindenes were prepared from methoxy-substituted
deoxybenzoins in three steps, as shown in Scheme I. The requisite deoxybenzoins were 
conveniently prepared by Friedel- Crafts acylation of anisole with phenylacetic acid. Preparations 
of compounds 4b, 4c, 5b, 5c, 6b, and 6c are described elsewhere.
9c, R ~ CF3
Structure-Receptor Binding Affinities Relatio n sh ip  The HR binding affinities (RBA) 
were determined in a competitive protein binding assay (see Table 1).
Using the protio compound 3a as a starting point, the order of increasing RBA follows the 
sequence 3a<3b<3c, which parallels that of increasing size and torsional influence of the ortho- 
substituents: H<Cll3<CF3.5 This phenomena cannot, however, be ascribed to purely steric 
considerations. The Hpophilicity of the methyl and trifluoromethyl groups may have local 
effectsthat contribute to the ligands' increased binding affinities. The trifluoromethyl group's 
highly electron-withdrawing character appears to be no detriment to binding.
Tublc 1. Kstrogcn Receptor Binding Affinities"
3b CHj 30
3c CFj 38
‘Determined by competitive radiometric binding 
assay using rat uterine cytosol as a source of receptor, 
[3H]cslradiol as tracer, and dex Iran-coated charcoal 
as absorbant for free ligand6. 
bBinding affinities arc expressed relative to that of 
estradiol a  100 (RBA a  relative binding affinity) and 
arc the average of duplicate determinations
1 0
Scheme 1: a, R = II; b, R = CH3; c, R = CF3
O
n3c
OTM Q
R
BF3*SMc2 
-----------►
6 n i >
R
6a-c 3a, R -  H
b, R = CHj
c, R = CF3
Absorbance and Emission Properties. The absorbance and emission properities of 
compounds 3a-c were measured and compared to those of the basic chromophore 4-methoxy- 
trans-stilbene. which is inherent in somewhat altered form within the 2,3-diarylindene system 
(Table 2). Based upon these data, compounds 3a-c can be classified as "sterically hindered trans-
stilbenoids".7 They have lower extinction coefficients compared to 4-mcthoxv-trans-stilbenc due
to lower absorptivities induced by higher steric demands.
Table 2. Absorption and Emission Maxima of Indene Methyl Ethers 
Compared to 4-Mcthoxv-trans- stilbene*
OMe
Compound k.0, (nm) KnmAnm) e Stokes’ shift (cm*1)
814 304 354 27,800 4650
7a 318 412 19,600 7180
7b 280 409 12,400 11260
7c 290 420 11,800 10670
'"All spectra taken in EtOAc.
Another indication of steric disruption of stilbene planarity is increased Stokes' Shift 
(Energy .t»orbince • Energy nuore»cnc«)-9 Using this criterion, increasing planarity in the indenes 
studied can be ordered as follows: Q-trifluoromethylindene 7c<o-methylindene 7b<dimcthoxy- 
indene 7a. It is possible to approximate the torsional angle for the trans-srilbene unit of the indenes 
using the relationship cos20 = e jt ,  where 0 is the torsional angle, e0 and e are the extinction 
coefficients of the model planar compound (4-mcthoxy-trans-stilbcne. 8) and the test compound, 
respectively. Unfortunately, this method is only applicable to cases with idealized sp2 
hybridization,10 and since there are significant distortions of the olefinic bond angles in the indene 
system, such calculation would be misleading.
The data presented in this section are sound justification for a more in-depth investigation. 
The RBA's of compounds 3b and 3c are of sufficient caliber to be useful as probes for ligand 
binding studies. Unfortunately, the fluorescence profiles of these compounds are poor due to the
presence of the hydroxyl group on the pendant 3-ring. This problem cun be easily addressed, 
however, by simply removing it.
Experimental Section
General. Melting points (uncorrected) were determined on a Thomas-Hoover apparatus. 
Analytical thin-layer chromatography (TLC) was performed on Merck silica gel F-254 glass- 
backed plates. Flash chromatography was done as previously described,11 using Woelm 32-63 
pm silica gel.
Proton nuclear magnetic resonance ('H-NMR) spectra were obtained on a Varian XL-200 
(200 MHz) or a General Electric QE-300 (300 MHz) spectrometer; chemical shifts are reported 
downfleld from a tetramethylsilane internal standard (6-scale). Infrared (IR) spectra \<ere obtained 
on a Nicolet 700 spectrometer in the indicated phase: prominent and diagnostic peaks are reported. 
Ultraviolet (UV) spectra were determined with a Hewlett-Packard 8431A spectrophotometer. Low 
resolution mass spectra (MS) were done in the electron impact mode on the Varian CH-3 
spectrometer. The reported data follow the form of: m/z (intensity relative to base peak = 100). 
High resolution mass spectra (HRMS) were obtained in the electron impact mode on a Varian 
MAT-371 spectrometer. Elemental analyses were performed by the Microanalytical Service 
Laboratory of the University of Illinois.
Unless otherwise noted, a standard procedure for product isolation was used; this involved 
quenching by addition of wuter or an aqueous solution, exhaustive extraction with an organic 
solvent, washing the extracts, drying with MgS04, and solvent evaporation under reduced 
pressure. The quenching media, extraction solvents, and aqueous washes used are noted 
parenthetically after the phrase "product isolation."
Fluorescence. The corrected emission spectra were acquired on a Spex Fluorolog 111 
spectrofluorimeter.
Preparation of l-(4-Methoxvohenvn-2-Dhenvlethanone (4aV The appropriately substituted 
phenylacetic acid (16.5 mmol) and anisole (21.5 mmol) were added to polyphosphoric acid (PPA; 
lOx the weight of the acid). The mixture was stirred at 40-70°C and monitored by TLC. The
reaction was complete in 0.5 h. Product isolation (ice water, EtOAc, saturated NaHCOj) was 
followed by recrystallization from ether at -30°C. Three crops of white flakes were obtained (5.0 
g, 75%), mp 70-71°C (lit.11 74-75°C); IR 3010, 1670, 1600, 1575, 1510, 1265, 1220, 1170 env 
>; 'H-NMR (CDCI3) 6 7.90 (d, 2H, J = 9 Hz, ArEfi- -CX)-); 7.22-7.15 (m, 5H. H-Ph); 6.83 (d, 
2H, J = 9 Hz, A rtie -  to -CH3); 4.14 (s, 2H, -CH2-), 3.76 (s, 3H, -OCH3); MS (70 eV), 226 
(M+, 1), 135 (100), 107 (10), 77 (15). Anal, calc'd for C i5Hh 0 2: C, 79.62; H, 6.24. Found: 
C, 79.66; H, 6.33.
Preparation of l-(4-Methoxvphenvn-2-phenvl-3-(3-methoxvphenvl)-l-propanotie (5a). 
The following procedure was used to prepare compound 5a from 4a. Sodium hydride (8.6 mmol, 
50% dispersion in oil) was rinsed with hexane and suspended in THF (5 mL). The substituted 
deoxybenzoin (6.88), dissolved in THF (30 mL), was added dropwise over 1 h. After enolate 
formation was complete (c. 2 h), the enolate solution was transferred yia cannula into a solution of 
3-methoxybenzyl chloride (13.8 mmol) in THF (5 mL). The solution was heated at 40-50°C until 
the reaction was complete, as determined by TLC. Product isolation (5% HC1, ethyl acetate, brine) 
was followed by purification by flash chromatography (two runs, 9:1 pentane-THF) to give a 
yellowish oil, which solidified on standing (1.16 g, 76%): mp 93.5-94.5°C; IR 3010, 1670, 
1600, 1260, 1160 c m 1; 'H-NMR (CDCI3) 6 7.84 (d, 2H, J = 9 Hz, ArEflr -CO-); 7.17 (s, 5H, 
HPh-); 7.04 (t, 1H, J = 8 Hz, A rE m - to -CH2-); 6.76 (d, 2H, J = 9 Hz, A rEm - to -CO-=); 
6.62-6.50 (m, 3H, A rE li- and fi- to -CH2-); 4.68 (t, IH, J = 7 Hz, -CEO; 3.73 (s, 3H, -OCEi 
C- to -CO-); 3.61 (s, 3H, -OCE3 m- to -CH2-); 3.47 (dd, 1H, J = 14 Hz, 7 Hz, -CE2-). 2.95 
(dd, 1H, J = 14 Hz, 7 Hz, -CE2-); MS (10 eV), 346 (M+, 3), 226 (1), 135 (100), 84 (15). 
HRMS calc'd/found (C23H220 3) 346.1590/346.1563.
Procedure for Preparation of 2-Phenvl-3-(4-methoxvphenvn-6-methoxvindene (7a). The 
triarylketone 6a was mixed with lOx its weight of polyphosphoric acid. The mixture was stirred 
mechanically under nitrogen at 45°C and the extent of reaction was monitored by TLC. Product 
isolation (ice water, EtOAc, 10% NaHCOs) afforded the crude product, which was purified by 
recrystallization from EtOAc at -30°C, yielding a white solid, 69% yield (657 mg); an analytical
specimen was obtained by a second recrystallization from methanol: mp 155-156.5°C; IR 3 005, 
1610, 1510, 1245 cm '; 'H-NMR (acetone-d*) 6 7.32-6.98 (m, 11H, ArH); 6.85 (dd, 1H, J = 8 
Hz, 2 Hz ArJiji- to -CH2-); 3.88 (s, 2H, -Q b-); 3.85 (s, 3H, -OCHj); 3.83 (s, 3H, -OCHs). 
MS (70 eV), 328 (M+, 100), 313 (20), 297 (14), 285 (20), 270 (12), 252 (41), 239 (56), 226 
(27), 215 (31), 208 (22), 165 (40). Anal, cacl'd for C23H20O2: C, 84.12; H, 6.14. Found: C, 
84.00; H, 6.22.
General Procedure for Methvl Ether Deorotection. This method was used for the 
preparation of 3a-3c. Boron trifluoride-dimethyl sulfide complex was prepared as previously 
described.12 The substrate (compounds 7a-c typically 0.3 mmol) was dissolved in CH2CI2 (ca. 10 
mL) and the solution was cooled to 0°C. A large excess of BF3-S(CH3)213 was added (4 mL of 
1:1 w/w solution). The reaction was followed TLC and was typically complete within 24 h. 
Product isolation (water, EtOAc) was followed by purification as described.
2-Phcnvl-3-(4-hvdroxvphenvl)-6-hvdroxvindcnc (3a). This compound was purified by 
preparative TLC (7:3 hexane-EtOAc, 2 developments). This compound was eluted from the silica 
with EtOAc; concentration and recrystallization from hexane-diisopropyl ether at -30°C provided a 
light tan solid (53 mg, 65%): mp 235°C dec; 'H-NMR (acetone-d^) 6 8.40 (br s, 2H, ArOH); 
7.31 (d, 2H, J = 8 Hz, ArHm- to -OH on 4-HOAr-); 7.23-7.01 (m, 7H, ArH); 6.92 (d, 2H, J = 8 
Hz, ArH 2- to -OH on 4-HOAr-); 6.77 (dd, 1H, J = 8 Hz, ArHg- to -CH2-); 3.83 (s, 2H, -CH2- 
). MS (70 eV), 300 (M+, 100), 283 (5), 207 (4). HRMS, cacl'd/found (C 2 |H ,60 2) 
300.1150/300.1148.
2-(2-Methvlphenvl)-3-(4-hvdroxvphenvl)-6-hvdroxyindene (3b). Flash chromatography 
(73:27 hexane-EtOAc), followed by recrystallization from isopropanol-pentane at -30°C gave off- 
white crystals (96 mg, 95%): mp 120°C; 'H-NMR (acetone-d*) 6 8.28 (s, 1H, ArOH), 8.14 (s, 
1H, ArOH), 7.25 (d, 2H, J = 8 Hz, ArHm- to -OH on 3-ring), 7.19-7.03 (m, 5H, ArH). 6 81 
(dd, 1H, J = 8 Hz, 1 Hz, ArH e- to -CH2-), 6.76 (d, 2H, J = 8 Hz, ArH 2- to -OH on 3-ring), 
3.68 (s, 2H, -CH2-). 1-96 (s, 3H, -CU3); MS (70 eV), 314 (M+, 100), 299 (10). HRMS, 
calc'dVfound for C22H18O2 314.1307/314.1305.
2-(2-Trifluoromethvlphenvl)-3-(4-hvdroxvphcnvl)-6-hvdroxvindine (3c). Purification 
was achieved by flash chromatography (4:1 hexane-EtOAc); a yellowish solid was obtained (45 
mg, 61%): mp 73nC dec; *H-NMR (acetone-d6) 8 8-18 (s, 1H, ArOftX 8.13 (s, 1H, ArOU), 
7.68-7.23 (m, 4H, ArU), 7.19 (d, 2H, ArHm- to -OH on 3-ring), 7.08 (d, 2H, ArUfi- andm* to 
-CH2-), 6.78 (dd, 1H, J = 8, 1 Hz, ArEfi- to -CH2-), 6.72 (d, 2H, J = 9 Hz, ArHfl- to -OH on 
3-ring), 3.70 (s, 2H, -C Jk ), MS (10 eV), 368 (M+, 50), 299 (6), 223 (7), 87 (18), 69 (8), 45 
(100). HRMS, calc’d/found for C22H |5F30 2 368.1024/368.1018.
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Our discovenes of the detrimental effects of hydroxylation of the pendant 3-ring in the 2,3- 
diarylindene systems on both RBA and fluorescence properties prompted us to abandon that 
investigation and to concentrate on simply modifying the torsional angles of the pendant rings. To 
these ends, compounds 13f-13h (T ab le  3) were made and their receptor binding and fluorescence 
properties examined.
The rationale behind the choice of substituents is similar to that used in the studies on the 
dihydroxylated analogs. We wanted to establish a torsional angle gradient by using small 
substituents (fluorine) and larger ones (methyl) that would impart more steric strain to the pendant 
ring environment. Also, by placing the same substituent alternately on each ring, we hoped to 
establish whether the observed binding results were due strictly to steric considerations or if there 
was also a site-specific interaction of some kind (lipophilic, electronic, etc.).
Results and Dkcussioa
Synthesis. Since deoxybenzoins llh-j were not optimally suited to synthesis through 
Friedl-Crafts acylation of substituted phenylacetic acids, these compounds were generated via their 
phosphonate precursors 9d,e (Scheme II).
Smicture-RgfigptQr Binding Affinity Relationships, The RBAs of compounds 13 h-j are 
given in table 3, along with protio compound 14 for comparison. It can be seen that the RBA 
increases with increased bulk of the Q-substituent on the pendant 2-ring. This could be due to 
increased torsional angles of the pendant rings, which would impart upon this molecule the bulk 
necessary to fit more tightly into the larger hormone's receptor site.
The ligand with the fluorine substituent on the pendant 2-ring has an RBA 2.5 times that of 
the ligand with the fluorine on the pendant 3-ring. Since X-ray crystal structures were not obtained 
for these compounds, it is impossible to ascribe a specific cause to this disparity. Were one to 
assume that the crucial torsional angles would be constant for the two compounds, then it would
Scheme II: 17
CHO
R
1) NaH, THF
2)
1) h2Nm ( p y -—NO2
Dean-Stark trap
2) (Ph0)2P(0)H
O 
II
(PhO^-P-CH
r NH_© ~
NOj
9d , e
d. R = F; e, R « H
CHO
R'
3) HC1, MeOH
10 f, R = F, R' = H 
g ,R « F , R' = H 
h R = H, R' = CH3
11 f-h
PPA
12 f-h
BF3*SMe2
■ 1 "■....
13 f, R = F, R' = H
g, R -  F, R' = H
h, R = H, R* = CH3
seem reasonable to attribute the marked difference in RBA to some site-specific interaction. This 
reasoning would still be tenuous at best, however, because one cannot be certain that the structure 
of a given compound in its crystal lattice will mimic that of the same compound in the actual 
estrogen receptor binding site, or even in solution. Therefore, while all of these possibilities art
Table 3. Estrogen Receptor Binding Affinities*
H 13f-h
Compound R R ’ RBAb
14' II II 8.9
13f F H 20
13g H F 50
13h H CHj 100
'Determined by competitive radiometric binding 
assay using rat uterine cytosol as a source of receptor, 
i3H]estradiol as tracer, and dextran-coated charcoal 
as absorbant for free ligand2. 
bBinding affinities are expressed relative to that of 
estradiol = 100 (RBA = relative binding affinity) and 
are the average of duplicate determinations
interesting to think about, they are as of yet untenable as rational conclusions.
Absorption and Emission Properties. Such promising results in the area of binding 
affinities as displayed by compounds 14h-j prompted us to investigate their performances against 
other criteria for fluorescent ligands, namely, their fluorescence profiles. To probe this area, it was 
necessary to observe certain essential emission properties. They are the maximum emission 
wavelength, extinction coefficient, and Stokes' shift imparted to the trans-stilbene ehromophore by 
substitutions made on the pendant rings of the indene system (Table 4).
Some structural information can be gleaned from a qualitative inspection of the trends in 
extinction coefficients (e) and Stokes' shifts of compounds (15-13j, Table 4). Steric hindrance to 
planarity in stilbenes manifests itself through increased Stokes' shifts (EnergyabSorbance - 
Energycmission) in those compounds.3 Applying this trend to the indenes s d, a "torsional
Table 4. Absorption and Emission Maxima of Indene j 9
Methyl Ethers Compared to Protio Compound 15
Compound X* (nm) m« (nm) e Stokes' shift (cm 1)
12 316 426 22,500 8170*
13h 298 423 11,600 10800b
13i 306 422 15,400 8983"
13j 314 421 17,700 8090b
•Run in MeOH; '’Run in EtOAc
hierarchy" can be established, where, in order of decreasing planarity: 13f>13g>13h. The 
anomalous value for the reference compound, which should be the most planar of the four, is 
probably due to solvent effects.
The above hierarchy is consistent with conclusions drawn from the trend in extinction 
coefficients (e), which is also influenced by steric perturbations. More sterically hindered indenes 
will have reduced extinction coefficients due to perturbations of the trans-stilbene chromophore.4 
For example, compound 13h has the lowest extinction coefficient, consistent with its hypothesized 
greater steric strain.
The maximum emission wavelength of each compound tested was too low to be 
distinguished from those in the range of cellular autofluorescence. This is not catastrophic, 
however, because these compounds are donor-only model compounds. With the addition of the 
appropriate acceptor group, the emission wavelengths of these compounds could be 
bathochromically shifted to higher, more useful ones.
Conclusion
The results o f this investigation are very encouraging. The compounds described herein 
bind quite respectably to the estrogen receptor. The problem to be addressed is the dichotomy 
between binding affinity and fluorescence in a given molecule. As can be seen from the data 
presented, the larger the steric perturbation conferred on the indene system, the larger the RBA. At 
the same time, though, one witnesses a decrease in vital fluorescence properties due to the 
interruption of conjugation of the trans-stilbene chromophore. Clearly, a middle ground must be 
attained.
One final consideration that must be kept in mind is that this study encompassed a very 
limited number of compounds. Drawing any firm conclusions based on such a paucity of data is
always risky.
Experimental
General. Melting points (uncorrected) were determined on a Thomas-Hoover apparatus. 
Analytical thin-layer chromatography (TLC) was performed on Merck silica gel F-254 glass- 
backed plates. Flash chromatography was done as previously described,5 using Woelm 32-63 pm 
silica gel.
Proton nuclear magnetic resonance (,H-NMR) spectra were obtained on a Varian XL-200 
(200 MHz) or a General Electric QE-300 (300 MHz) spectrometer; chemical shifts are reported 
downfield from a tetramcthylsilane internal standard (6-scale). Infrared (IR) spectra were obtained 
on a Nicolet 700 spectrometer in the indicated phase: prominent and diagnostic peaks are reported. 
Ultraviolet (UV) spectra were determined with a Hewlett-Packard 8451A spectrophotometer. Low 
resolution mass spectra (MS) were done in the electron impact mode on the Varian CH-5 
spectrometer. The reported data follow the form of: m/z (intensity relative to base peak = 100). 
High resolution mass spectra (HRMS) were obtained in the electron impact mode on a Varian 
MAT-371 spectrometer. Elemental analyses were performed by the Microanalytical Service 
Laboratory of the University of Illinois.
Unless otherwise noted, a standard procedure for product isolation was used; this involved 
quenching by addition of water or an aqueous solution, exhaustive extraction with an organic 
solvent, washing the extracts, drying with MgSC>4, and solvent evaporation under reduced 
pressure. The quenching media, extraction solvents, and aqueous washes used are noted 
parenthetically after the phrase "product isolation."
Fluorescence. The corrected emission spectra were acquired on a Spex Fluorolog 111 
spectrofluorimeter.
General Procedure for the Formation of Phosohonatcs, This method was used to prepare 
compounds 9d,e. 4-Nitroaniline and the appropriate aldehyde (2-fluorobcnzaldehyde for 9d;
benzaldehyde for 9e) were dissolved in benzene and heated to reflux for 24 h. A Dean-Stark trap 
was used to periodically remove water and wet benzene; fresh benzene was added. 
Diphenylphosphite was added and the solution was heated at reflux for another 12 h, with 
intermittent water/wet benzene removal and benzene replenishment. The solvent was evaporated 
under reduced pressure and the residue was purified as described.
Diphcnvl-(2-fluorophenvl)-(4-nitrophenvlamino)-methanephosphonate (9d). Trituration 
with 1:1 EtOAc-ether afforded a pale yellow solid (30.6321g, 82%): mp 136-137°C; 'H-NMR 
(CDCI3) 8 8.03 (d, 2H, J = 9.3 Hz, ArU q- to -N 02); 7.56 (dt, 1H, J » 7.5 Hz, 2.5 Hz, Aril q- 
to -F); 7.35-7.07 (m, 11H, ArU); 6.80 (m, 2H, ArU); 6.62 (d, 2H, J -  9.3 Hz, ArU in- «> -N 02); 
5.87 (bt, 1H, J = 8.9 Hz, 8.5 Hz -NU-); 5.68 (d, 1H, J = 8.5 Hz, -CU-); 5.55 (d, 1H, J = 8.9
Hz,-CU-). MS (10 eV), 478 (M+, 2), 245 (100), 234 (32). Anal, cacl'd for C25H2oFN20 5P: 
C, 62.79; H, 4.22; N, 5.86; F, 3.97: P, 6.48. Found: C, 62.68; H, 4.12; N, 5.89; F, 3.61; P, 
6.41.
Diphenvl-(4-nltrophenylamino)-phenvlmcthancphosphonate (9e). Trituration with 1:1 
EtOAc-ether gave a pale yellow powder. A second crop was obtained by concentration of the 
mother liquors and recrystallization (ether, -30°C). The total yield was 44.8 g (94%): mp 156- 
157.5°C; IR 1600, 1490, 1330, 1315, 950 crn-l;1 H-NMR (CDCI3) 8 7.98 (d, 2H, J = 9 Hz, ArU 
C- to -NCh); 7.60-7.06 (m, 13H, ArU); 6.73 (d, 2H, J = 8 Hz, ArU); 6.57 (d, 2H, J = 9 Hz, ArU 
2- to -NH-); 6.30 (br s, 1H, -NU-); 5.20 (d, 1H, J = 8.2 Hz, -CH-). MS (70 eV), 460 (M+, 1), 
235 (35), 227 (100), 179 (6), 94 (62). Anal, cacl’d for C25H2i N->OsP: C, 65.22; H, 4.60; N, 
6.80; P, 6.73. Found: C, 65.07; H, 4.62; N, 6.07; P, 6.75.
Preparation of Deoxvbenzoins from Phosohonates. Sodium hydride (40 mmol) was 
washed with hexane and suspended in freshly distilled THF. The appropriate phosphorate (30 
mmol) was dissolved in THF and added dropwise for 1 h. The anion was generated for 2.5 h. 
Benzaldehyde (30 mmol) was then dissolved in a small amount of THF (typically 15 mL) and 
added over 30 min. The solution was stirred for 20 h and reaction was followed by TLC. When 
deemed complete, solvent was removed under reduced pressure and the resulting oil was refluxed
in McOH-HCI for 5-8 h, again following the reactions progress by TLC. Product isolation (ice 
water, EtOAc, brine) was followed by purification as described
1 -(2-Fluorophcnyl)-2-phenvlethanone (10f). Flash chromatography (2 runs, 20% EtOAc- 
hexane followed by 3% EtOAc-hexane) yielded a clear oil (2.3685 g, 33%) which, upon standing, 
solidified to give white needles, mp 101-103°C. 'H-NMR (CDCI3): 6 7.85 (dt, 1H, J = 7.6 Hz, 
1.2 Hz, ArUfl- to -F); 7.49 (m, 1H, ArHfi- to carbonyl); 4.29 (d, 2H, J = 2.4 Hz, -CHr); 7.37- 
7.08 (m, 7H, ArH). MS (70 eV); 214 (M+, 5), 123 (100). Anal, cacl'd for C MH|,FO: C, 
78.49; H, 5.18; F, 8.87. Found: C, 78.23; H, 5.00; F, 8.62.
1 -Phenvl-2-(2-fluorophenvn-ethanone (1 Qg). Flash chromatography (20% EtOAc-hexane) 
yielded white crystals (1.90 g, 34%), mp 75-76°C. 'H-NMR (CDCI3): 8 8.05 (dt, 2H, J = 6.5 
Hz, 1.7 Hz, ArHfi- to -CO-); 7.59-7.44 (m, 3H, ArH); 7.29-7.04 (m, 4H, ArH); 4.33 (s, 2H, - 
CH2-). MS (70 eV): 214 (M+, 2), 105 (100). Anal, cacl'd for Cl4Hn FO: C, 78.49; H, 5.18; 
F, 8.87. Found: C, 78.63; H, 5.25; F, 8.72.
1 -Phenvl-2-(2-methvlphenvl)cthanone ( lQh), Flash chromatography (2 runs, 20% EtOAc- 
hexane followed by 4% EtOAc-hexane) followed by recrystallization (pentane, -30°C) yielded 
white crystals (.8191 g, 36%), mp 69-70°C. 'H-NMR (CDCI3): 8 8.03 (dd, 2H, J = 8.3 Hz, 
1.45 Hz, ArHfi- to -CO-); 7.59-7.44 (m, 3H, ArH); 7.23-7.11 (m, 4H, ArH); 4.31 (s, 2H, - 
CH2-). 2.26 (s, 3H, -CHs). MS (70 eV): 210 (M+, 7), 105 (100), 77 (6). Anal, cacl'd for 
C15H14O: C, 85.68; H, 6.71. Found: C, 85.42; H, 6.72.
Procedure for 3-Methoxvbenzvlation of Deoxvbenzoins. This method was used to prepare 
compounds 1 lf-1 lh. A representative protocol is given for the synthesis of l-(2-fluorophenyl)-2- 
phenyl-3-(3-methoxyphenyl)-l-propanone (110.
Sodium hydride (210 mg, 5.1 mmol) was washed with hexane and suspended in 10 mL of 
freshly distilled THF. Deoxybenzoin () (1.0 g, 4.7 mmol) was dissolved in 30 mL of THF arvi 
added dropwise over 30 min. The enolate was allowed to form for another 30 min, then the 
solution was transferred via cannula to another flask containing neat 3-methoxybenzyl chloride and 
the reaction was stirred for 48 h. Product isolation (5% HC1, EtOAc, brine) and flash
chromatography (9:1 pentane-THF) yielded a clear oil (1.19 g, 76%). !H-NMR (CDCI3): 8 7?0 
(dt, 1H, J = 7.6 Hz, 2.0 Hz, ArU a- to -F); 7.37 (m, 1H, ArU); 7.25-6.94 (m, 8H, ArU); 6.69 
(dd, 2H, J = 7.8 Hz, 2.5 Hz, ArU a* and m- to -OCH3). MS (10 eV): 334 (M+, 53), 211 (72), 
123 (100). Anal, cacl'd for C22H ,9F 0 2: C, 79.02; H, 5.73; F, 5.68. Found: C, 79.10; H, 
5.81; F, 5.79.
1- Phenvl-2-(2-fluorophenv0-3-(3-methoxvVl-propanonc HI e l  Flash chromatography 
(5% EtOAc-hexane) yielded a colorless oil (790 mg, 62%). ’H-NMR (CDCI3): 8 7.93 (d,2H ,J 
= 7.6 Hz, A ril a- to -CO-); 7.46-6.94 (m, 8H, Aril); 6.71 (m, 4H, Aril); 5.24 (t, 1H, J = 7.3 
Hz, -CH-); 3.70 (s, 3H, -OCU3); 3.53 (dd, 2H, J = 13.6 Hz, 7.6 Hz, -CU r): 3.03 (dd, 1H, J -  
13.6 Hz, 7.0 Hz, -C H r). MS (70 eV): 334 (M+, 53), 229 (27), 121 (28), 105 (100). Anal, 
cacl'd for C22Hi9F 0 2: C, 79.02; H, 5.73; F, 5.68. Found: C, 78.89; H, 5.58; F, 5.69.
1 -Phcr.vl-2-(2-mclhvlphcnvP-3-(3-mcthoxvphenvP-1 -propanone (11 hi. Purified by Hash 
chromatography (5% EtOAc-hexane) yielded a clear oil (1.01 g, 82%). 'H-NMR (CDCI3): 8 7.78 
(dd, 1H, J = 8.3 Hz, 1.6 Hz, ArU a- to -CO-); 7.43-7.08 (m, 8H, ArU); 6.70 (dd, 2H, J = 8.1 
Hz, 2.3, ArU fi- and m- to -OCH3); 4.93 (t, 1H, J = 7.4 Hz, -CU-); 4.51 (dd, 2H, J = 7.2 Hz, - 
CU2-); 3.67 (s, 3H, -OCU3); 2.92 (dd, 2H, J -  6.7, -CU2-); 2.24 (s, 3H, -CU3). MS (70 eV): 
330 (M+, 48), 225 (30), 105 (100). Anal, (exact mass, HREIMS) cacl'd for C7Ht0 7 m/e: ?. 
Found: 330.1619
General Procedure for Polvphosphoric Acid Cvclizations. This method was used to 
prepare compounds 12f-h. It simply involves stirring the appropriate ketone with PPA at 50°C for 
6 h. The reaction was monitored by TLC. Product isolation (ice water, EtOAc, brine) was 
followed by purification as described.
2 - P henvl-3-(2-fluoroohenvl)-6-m ethoxvindene (12fi. Purification by flash 
chromatography (2 runs, 20% EtOAc-hexane and 10% EtOAc-hexane) yielded a white solid (522 
mg, 55%) mp 109-110°C. 'H-NMR (CDCI3): 8 7.44-7.18 (m, 9H, ArU); 7.13 (d, 2H, J = 2.2 
Hz, ArU a- to -OCH3); 7.01 (dd, 1H, J = 8.1 Hz, 1.2 Hz, ArUm- to -OCH3); 6.83 (dd, 1H, J = 
8.5 Hz, 2.2 Hz, ArU a- to -OCH3); 3.93 (s, 2H, -CII2 ); 3.85 (s, 3H, -OCU3). MS (70 eV):
316 (M+,100), 301 (6), 273 (3). Anal, cacl’d for C22H i7FO: C, 83.52; H, 5.42; F, <3)1 
Found: C, 83.44; H, 5.53; F, 5.85.
2-(2-FluoroDhenvl)-3-Dhcnvl-6-methoxvindene (12e). Trituration (cthcr-pcntanc) gave a 
pale yellow solid (322 mg, 54%), mp 106-107 5°C. ‘H-NMR (CDCI3): 8 7.33-6.95 (m, 10H, 
ArH); 6.88 (dd, 2H, J = 8.4 Hz, 2.3 Hz, ArHfl- and m- to -OCH3); 3.91 (s, 2H, -C H r); 3.86 
(s, 3H, -OCHj). MS (70 eV): 316 (M+, 83), 301 (20), 142 (16) 58 (100). Anal, cacl’d for 
C22H i7FO: C, 83.52; H, 5.42; F, 6.01. Found: C, 83.38; H, 5 47; F, 5.96.
2-(2-M ethvlphenvl)-3-phenvl-6-m ethoxvindene (12h). Purification by flash 
chromatography (20% EtOAc-hexane) yielded a white solid (342.4 mg, 52%), mp 117-119°C. 
‘H-NMR (CDCI-i): 8 8.89 (dd, 1H, J = 8.7 Hz, 2.6 Hz, Arllfl- to -OCH3); 7.38 (d, 111, J = 
8.7 Hz, ArHm- to -OCH3); 7.24-7.09 (m, 10H, ArH); 3.87 (s, 3H, -OCHj ); 3.77 (s, 2H, -CU2- 
); 1.97 (s, 3H, -CHb). MS (70 eV): 312 (M+, 100), 297 (5), 281 (4). Anal, cacl'd for 
C23H20O: C, 88.43; H, 6.45. Found: C, 88.17; H, 6.50.
Deprotection with Boron trifluoride-dimethvl sulfide. This procedure was used to obtain 
final products 13f-h. To the methyl ether (typically 120 mg), dissolved in CH2C12, was added 
boron trifluoride-dimethyl sulfide complex (3.5 mL). This solution was stirred at room 
temperature for 12-32 h and followed by TLC. When deemed complete, product isolation (water, 
EtOAc, brine) was followed by purification as specified.
2-Phcnvl-3-(2-fluorophenvl)-6-hvdroxvindcne (13f). Flash chromatography ( 20% 
EtOAc-hexane) was followed by trituration (ether-pentane) to yield a white solid (67.8 mg, 59%), 
mp 140-14J°C. ‘H-NMR (CDC13): 8 7.96 (dd, 1H, J = 8.3 Hz, 1.2 Hz, ArH m - to -OH); 
7.40-7.13 (m, 9H, ArH); 7.05 (d, 1H, J = 2.2 Hz, ArHfi- to -OH); 6.75 (dd, 1H, J = 8.3 Hz, 
2.2 Hz, ArHfl- to -OH); 4.64 (s, 1H, ArOH); 3.92 (s, 2H, -CJth-). MS (70 eV): 302 (M+, 100), 
207 (2). Anal, cacl'd for C2iH i5F0: C, 83.42; H, 4.96; F, 6.28. Found: C, 83.03; H, 4.86; 
F, 5.90.
2-(2-FluoroDhenyl)-3-phcnvl-6-hydroxvindene (13g). Flash chromatography (20% 
EtOAc-hexane) and recrystallization (hexane-isopropyl alcohol, -30°C) yielded an off-white solid
(66.2 mg, 64%), mp 132-133°C. 'H-NMR (CDCI3): 8 7.32 (s, 5H, ArH); 7.30-6.87 (m, 6H, 
ArH); 6.77 (dd, 1H, J -= 8.0 Hz, 2.4 Hz, ArHfi- to -OH); 4.70 (vbr s, 1H, -OH); 3.89 (s, 2H, - 
CH2-)- MS (70 cV): 302(M \ 100), 224 (2). Anal, cacl'd for C2iH15FO: C, 83.42; H, 5.00; 
F, 6.28. Found: C, 83.49; H, 4.98; F, 6.32.
2-(2-Methylphenvl)-3-phenvl-6-hvdroxvindcnc (13h). Crystallization (pentane-ether) 
yielded a fine white solid (123.5 mg, 43%), mp 159-160.5°C. 'H-NMR (CDCI3): 8 7.33 (d, 
1H, J -  8.3 Hz, ArHm- to -OH); 7.21-7.09 (m, 9H, ArH); 7.06 (d, 1H, J = 2 Hz, ArHfl- to - 
OH); 6.81 (dd, 1H, J = 8.3 Hz, 2.6 Hz, A rH a- to -OH); 4.65 (s, 1H, -AiOU); 3.75 (s, 211, - 
CH2-); 1.97 (s, 3H, ArQH). M S(70eV): 298 (M+, 100), 283 (10), 207 (16). Anal, cacl'd for 
C22H i80 :  C, 88.56; H, 6.08. Found: C, 88.45; H, 6.19.
References
1. Anstead, G. M.; Peterson, C. S.; Katzenellenbogen, J. A. Molecular Pharmacology, 
submitted, 1988.
2. Katzenellenbogen, J. A.; Johnson, H. J., Jr.; Myers, H. N. Biochemistry. 1973,12. 4085.
3. Fischer, G.; Seger.G.; Muszkat, K. A.; Fischer, E. J. Chem. Soc. Perkin 11. 1975, 1569 and 
references cited therein.
4. Anstead, G. M.; Altenbach, R. J.; Wilson, S. R.; Katzenellenbogen, J. A. J. Med. Chem.. in 
press, 1988.
5. Still, W. C.;, Kahn, M.; Mitra, A. J. Ore. Chem.. 1978, 42, 2923.
SECTION IV
2 6
introduction*
Puring the course of synthetic work on indene systems like those described in this thesis, 
compound 16 was isolated as a by-product of the following reaction sequence (Scheme III).
The assignment of the structure shown was indicated by mass, *H-NMR, and 1R 
spectroscopies anil elemental analysis. This structure was later confirmed by single-crystal X-ray 
crystallography. It was believed that the priapic electron-rich methoxyphenyl and electron-deficient 
nitrophcnyl rings might confer some peculiar electronic and spectroscopic properities upon this 
molecule, so a deliberate synthesis of it was undertaken.
R esults and  .P ism saiflo ,
Initial attempts at pre-meditated synthesis of the immediate precursor to indanoindane 6, 
involving alkylation of the mono-bcnzvl ketone 17, were unsuccessful (Scheme IV).
Scheme IV.
Strangely, under conditions conducive to O-alkylation (sodium enolate, DMF),1 hi&-C- 
alkylation of nitrodeoxybenzoin was effected in reasonably good yield (61%). Subsequent 
cydization yielded the desired product 16 (Scheme V).
Scheme 111 2 7
OCH,
N(>2
16
Figure 1: Atomic numbering scheme for 15 2 9
Structural Considerations. Analysis of the X-ray crystal stucture obtained shows specific 
areas which exhibit various strains (Figure 2). Most of the general strain in the system is 
concentrated around C-13 (Figures 1 and 2, Table 5).
Table V. Selected bond lengths and bond angles for compound 16*
Angle deg Bond length (A)
C4-C5-C13 102.0 C13-C23 1.523
C5-C13-C14 102.3 C13-C12 1.529
C13-C5 1.618
C13-C14 1.522
♦Adapted from reference 2.
Figure 2. Regions of high strain energy in 16: A, bond stretching; B, 
angle bending; C, torsional.
‘H-NMR Spectrum. The priapic rings in compound 16 produce a condition of mutual 
shielding, shifting protons on the rings upfield by 0.3-0.5 ppm relative to model compounds3 
(Figure 3).
OCH3
6.33
6.45
OCH3
7.06
7.81
Figure 3. Field position of aromatic protons of priapic rings of 16 
compared to model compounds3; shifts are in ppm on 
the 8 scale.
Conclusion
The discovery of the "accidental" synthesis of compound 16 was truly serendipitous. The 
close but skewed juxtaposition of the priapic aryl rings provides a model system for the study of 
charge-transfer processes,4 x-x* transannular interactions,5 photosynthesis,6 bonding and strain7 
and stacking.8 Based on findings given here and elsewhere2* this compound could well merit 
further investigation.
Experimental Section
General. Melting points (uncorrected) were determined on a Thomas-Hoover apparatus. 
Analytical thin-layer chromatography (TLC) was performed on Merck silica gel F-254 glass- 
backed plates. Flash chromatography was done as previously described,9 using Wcelm 32-63 pm 
silica gel.
Proton nuclear magnetic resonance OH-NMR) spectra were obtained on a Varian XL-200 
(200 MHz) or a General Electric QE-300 (300 MHz) spectrometer; chemical shifts are reported 
downfleld from a tetramethylsilane internal standard (6-scale). Infrared (IR) spectra were obtained 
on a Nicolet 700 spectrometer in the indicated phase: prominent and diagnostic peaks are reported. 
Ultraviolet (UV) spectra were determined with a Hewlett-Packard 8451A spectrophotometer. Low 
resolution mass spectra (MS) were done in the electron impact mode on the Varian CH-5 
spectrometer. The reported data follow the form of: m/z (intensity relative to base peak = 100). 
High resolution mass spectra (HRMS) were obtained in the electron impact mode on a Varian 
MAT-371 spectrometer. Elemental analyses were performed by the Microanalytical Service 
Laboratory of the University of Illinois.
Unless otherwise noted, a standard procedure for product isolation was used; this involved 
quenching by addition of water or an aqueous solution, exhaustive extraction with an organic 
solvent, washing the extracts, drying with MgSC>4, and solvent evaporation under reduced 
pressure. The quenching media, extraction solvents, and aqueous washes used are noted 
parenthetically after the phrase "product isolation."
l-(4-Methoxyphenvl)-2-(4-nitrQohenvl)-2-(3-methoxvbenzvl):3-(4-methoxYPhfinyl)-l- 
propanone (15). Sodium hydride (410 mg, 8.54 mmol, 50 % dispersion in oil) was rinsed with
hexane and suspended in DMF (5 mL). Nitrodeoxybenzoin (1.0 g, 3.69 mmol), dissolved in 
DMF (13 mL) was added dropwise over 15 min. The enolate was generated for 3 h. Lithiium 
iodide (60 mg, 0.45 mmol) and 3-methoxybenzyl chloride (2.3 g, 14.7 mmol) were added 
sequentially. The solution was heated at 60° C for 48 h. Product isolation (5% HC1, EtOAc, 
brine), followed by flash chromatography (19:1 hexane-F.tOAc) afforded a white solid (1.15 g, 
61%) of a slightly higher Rf than the starting ketone: mp 76-78°C; 'H-NMR (CDCI3) 8 8.10 (d, 
2H, J = 9 Hz, ArH q- to -N 02), 7.58 (d, 2H, J « 9 Hz, ArH q- to -CO ), 7.23 (d, 2H, J = 9 Hz, 
ArHm- to -N 02), 7.03 (t, 2H, J = 9 Hz, ArHm- to -CH2-), 6.75 (d, 2H, J = 9 Hz, ArHm- to - 
CO-), 6.68 (dd, 2H, J = 9 Hz, 2 Hz, Ar£U- to -CH2), 6.41 (d, 2H, J = 9 Hz, ArHfi- to -OCH3), 
6.36 (d, 2H, J = 2 Hz, ArH e- to -Cll2-, -OCH3), 3.8! (s, 3H, -COArOCHa), 3.62 (s, 6H, two - 
OCH3), 3.31 (ABq, 4H, J = 18 Hz, two -CHr); MS (70 eV), 511 (M+, 1), 390 ( 1), 256 (4), 135 
(100), 121 (13). Anal calc'd for C3iH29N0 6: C, 72.78; H, 5.71; N, 2.79. Found; C, 72.93; 
H, 5.77; N, 2.59.
l-(4-Methoxvphenyl)-2-(4-nitrophenvl)-5.10-dimethQXvindanoH.2-alindane (16). fii&- 
bcnzylketone (366 mg) was mixed with polyphosphoric acid (PPA), (20 g) and the mixture was 
stirred mechanically under nitrogen at 40°C for 19 h. Product isolation (ice water, FtOAc, brine) 
and recrystallization from methanol at -30°C provided a maize-colored, micixxrystalline solid (153 
mg, 43%). The sample for X-ray crystallography was obtained by slow evaporation of methanol 
at 3°C: mp 213.5-214.5°C; IR c m 1; *H-NMR (CDCI3) 8 7.81 (d, 2H, J = 9 Hz, A rU a- to - 
N 0 2), 7.06 (d, 2H, J = 9 Hz, ArHm- to N 02), 7.01 (d, 2H, J  = 8 Hz, two ArHm- to -CH2-) 
6.90 (d, 2H, J = 2 Hz, two ArH a- to CH2-), 6.80 (dd, 2H, J * 8 Hz, 2 Hz, two A rlip - to - 
CH2), 6.45 (d, 2H, J = 9 Hz, ArHfl- to -OCH3 on pendant ring), 6.33 (d, 2H, J = 9 Hz, ArH in­
to -OCH3 on pendant ring), 3.83 (s, 6H, two -OCH3), 3.66 (J, 2H, J = 16 Hz, two -CH of - 
CH2-), 3.17 (d, 2H, J = 16 Hz, two -CH- of -CH2-); MS (70 eV), 493 (M+, 100), 385 (21), 372 
(41), 357 (16), 344 (29), 326 (7), 239 (9). Anal, calc'd. for C3iH 27N0 5: C, 75.44; H, 5.51; N, 
2.84. Found: C, 75.52; H, 5.56; N, 2.74.
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